| A randomized, double‐blind trial of abatacept (CTLA‐4Ig) for the treatment of giant cell arteritis CA Langford, D Cuthbertson, SR Ytterberg, N Khalidi, PA Monach, ... Arthritis & rheumatology 69 (4), 837-845, 2017 | 308 | 2017 |
| Treatment of lupus nephritis with abatacept: the abatacept and cyclophosphamide combination efficacy and safety study ACCESS Trial Group Arthritis & Rheumatology 66 (11), 3096-3104, 2014 | 236 | 2014 |
| New insights into mechanisms of therapeutic effects of antimalarial agents in SLE DJ Wallace, VS Gudsoorkar, MH Weisman, SR Venuturupalli Nature Reviews Rheumatology 8 (9), 522-533, 2012 | 234 | 2012 |
| A randomized, double‐blind trial of abatacept (CTLA‐4Ig) for the treatment of Takayasu arteritis CA Langford, D Cuthbertson, SR Ytterberg, N Khalidi, PA Monach, ... Arthritis & Rheumatology 69 (4), 846-853, 2017 | 163 | 2017 |
| S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease M Hardy, I Coulter, SC Morton, J Favreau, S Venuturupalli, F Chiappelli, ... Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2002 | 127 | 2002 |
| S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease M Hardy, I Coulter, SC Morton, J Favreau, S Venuturupalli, F Chiappelli, ... Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2002 | 127 | 2002 |
| Glucocorticoid‐induced osteoporosis S Silverman, S Venuturupalli Osteoporosis: Diagnosis and Management, 79-92, 2013 | 88 | 2013 |
| Klinefelter's syndrome (47, XXY) is in excess among men with Sjögren's syndrome VM Harris, R Sharma, J Cavett, BT Kurien, K Liu, KA Koelsch, ... Clinical Immunology 168, 25-29, 2016 | 87 | 2016 |
| MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE S Smith, T Fernando, PW Wu, J Seo, JN Gabhann, O Piskareva, ... Journal of autoimmunity 79, 105-111, 2017 | 72 | 2017 |
| Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons H Li, TR Reksten, JA Ice, JA Kelly, I Adrianto, A Rasmussen, S Wang, ... PLoS genetics 13 (6), e1006820, 2017 | 71 | 2017 |
| Previous diagnosis of Sjögren’s syndrome as rheumatoid arthritis or systemic lupus erythematosus A Rasmussen, L Radfar, D Lewis, K Grundahl, DU Stone, CE Kaufman, ... Rheumatology 55 (7), 1195-1201, 2016 | 63 | 2016 |
| Gastrointestinal and hepatic manifestations H DS Dubois's lupus erythematosus, 829-847, 2007 | 60 | 2007 |
| Macrophage fumarate hydratase restrains mtRNA-mediated interferon production A Hooftman, CG Peace, DG Ryan, EA Day, M Yang, AF McGettrick, M Yin, ... Nature 615 (7952), 490-498, 2023 | 57 | 2023 |
| Are Ayurvedic herbs for diabetes effective? PG Shekelle, M Hardy, SC Morton, I Coulter, S Venuturupalli, J Favreau, ... Frontline Medical Communications Inc., 2005 | 52 | 2005 |
| Ayurvedic interventions for diabetes mellitus: a systematic review. ML Hardy, I Coulter, S Venuturupalli, EA Roth, J Favreau, SC Morton, ... Evidence report/technology assessment (Summary), 2p.-2p., 2001 | 51 | 2001 |
| Ayurvedic interventions for diabetes mellitus: a systematic review. ML Hardy, I Coulter, S Venuturupalli, EA Roth, J Favreau, SC Morton, ... Evidence report/technology assessment (Summary), 2p.-2p., 2001 | 51 | 2001 |
| Brief Report: Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome R Sharma, VM Harris, J Cavett, BT Kurien, K Liu, KA Koelsch, A Fayaaz, ... Arthritis & Rheumatology 69 (11), 2187-2192, 2017 | 45 | 2017 |
| Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases JS Hausmann, K Kennedy, JF Simard, JW Liew, JA Sparks, TT Moni, ... The Lancet Rheumatology 3 (10), e707-e714, 2021 | 44 | 2021 |
| Effect of tobacco smoking on the clinical, histopathological, and serological manifestations of Sjögren’s syndrome DU Stone, D Fife, M Brown, KE Earley, L Radfar, CE Kaufman, DM Lewis, ... PLoS One 12 (2), e0170249, 2017 | 40 | 2017 |
| Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells B Khatri, KL Tessneer, A Rasmussen, F Aghakhanian, TR Reksten, ... Nature communications 13 (1), 4287, 2022 | 39 | 2022 |
